Holders — by stockHoldings — by fund
Atle Fund Management AB
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001381843
$373.4M
disclosed book value
39
positions
9.7%
largest position share
Positions, as of 2026-09-30
top 39 of 39 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | LLYELI LILLY & CO | 31,202 | $36.1M | 9.7% |
| 2 | MRKMERCK & CO. INC | 168,987 | $24.6M | 6.6% |
| 3 | JNJJOHNSON & JOHNSON | 91,387 | $24.2M | 6.5% |
| 4 | ABBVABBVIE INC | 91,294 | $23.9M | 6.4% |
| 5 | TMOTHERMO FISHER SCIENTIFIC CORP | 34,410 | $23.2M | 6.2% |
| 6 | BIIBBIOGEN INC | 70,955 | $16.0M | 4.3% |
| 7 | VRTXVERTEX PHARMACEUTICALS INC | 28,157 | $14.7M | 3.9% |
| 8 | RVMDREVOLUTION MEDICINES INC | 66,113 | $13.6M | 3.6% |
| 9 | ONCBEONE MEDICINES LTD-ADR | 35,679 | $13.1M | 3.5% |
| 10 | CVSCVS HEALTH CORP | 139,311 | $11.9M | 3.2% |
| 11 | CORCENCORA INC | 36,107 | $10.8M | 2.9% |
| 12 | BBIOBRIDGEBIO PHARMA INC | 163,697 | $10.8M | 2.9% |
| 13 | ISRGINTUITIVE SURGICAL INC | 25,648 | $10.4M | 2.8% |
| 14 | INSMINSMED INC | 87,469 | $10.0M | 2.7% |
| 15 | EWEDWARDS LIFESCIENCES CORP | 109,647 | $9.5M | 2.5% |
| 16 | SYKSTRYKER CORPORATION | 34,296 | $9.4M | 2.5% |
| 17 | INCYINCYTE CORP | 77,377 | $9.4M | 2.5% |
| 18 | KRYSKRYSTAL BIOTECH, INC | 28,074 | $9.3M | 2.5% |
| 19 | DXCMDEXCOM INC | 89,251 | $7.7M | 2.1% |
| 20 | NAMSNEWAMSTERDAM PHARMA CO NV | 303,824 | $7.4M | 2% |
| 21 | IRTCIRHYTHM TECHNOLOGIES INC | 54,102 | $6.1M | 1.6% |
| 22 | GILDGILEAD SCIENCES INC | 40,461 | $6.0M | 1.6% |
| 23 | MIRMMIRUM PHARMACEUTICALS INC | 70,071 | $6.0M | 1.6% |
| 24 | CAHCARDINAL HEALTH INC | 26,735 | $5.9M | 1.6% |
| 25 | BSXBOSTON SCIENTIFC | 130,622 | $5.7M | 1.5% |
| 26 | ALKSALKERMES PLC | 136,225 | $5.5M | 1.5% |
| 27 | NBIXNEUROCRINE BIOSCIENCES INC | 38,611 | $5.5M | 1.5% |
| 28 | TNGXTANGO THERAPEUTICS INC | 184,394 | $4.6M | 1.2% |
| 29 | ABVXABIVAX SA | 46,452 | $4.6M | 1.2% |
| 30 | SYRESPYRE THERAPEUTICS INC | 44,243 | $3.9M | 1.1% |
| 31 | ORKAORUKA THERAPEUTI | 43,180 | $3.6M | 1% |
| 32 | IDYAIDEAYA BIOSCIENCES INC | 93,550 | $3.6M | 1% |
| 33 | SMMTSUMMIT THERAPEUTICS INC | 184,687 | $3.1M | 0.8% |
| 34 | CMPSPATHWAYS PLC | 243,506 | $3.0M | 0.8% |
| 35 | IRONDISC MEDICINE INC | 43,682 | $2.9M | 0.8% |
| 36 | CELCCELCUITY INC | 29,893 | $2.4M | 0.6% |
| 37 | PVLAPALVELLA THERAPEUTICS INC NE | 14,924 | $2.1M | 0.6% |
| 38 | PYXSPYXIS ONCOLOGY INC | 663,772 | $1.5M | 0.4% |
| 39 | MANEVERADERMICS INC | 10,106 | $1.2M | 0.3% |
Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.